Suschak, John J.
2 papers on CoChatORCID 0000-0002-2867-8265
Most cited papers
- Verified
Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
Nestor, J. J., Parkes, D., Feigh, M., Suschak, J. J., & Harris, M. S. (2022) · Scientific Reports
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 53
- Verified
Pemvidutide, a glp-1/glucagon dual receptor agonist, significantly reduces liver fat, fibro-inflammation, and body weight in patients with non-alcoholic fatty liver disease: a 24-week multicenter, randomized, double-blind, placebo-controlled trial
Harrison, S., Tomah, S., Suschak, J., Roberts, S., Yang, J., He, L., Georges, B., Rodwell-Green, L., Brown, R., Harris, M. S., et al. (2023) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free